Evidence map›Paper›PMID 34925995›Full record

ArticleCureus2021

Opinion of German Immunologists on SARS-CoV-2: Results of an Online Survey.

Harald Walach, Viviane Ruof, Raffaele Hellweg

Abstract read
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Harald WalachResearch and Development, Change Health Science Institute, Berlin, DEU.
Viviane RuofResearch and Development, Change Health Science Institute, Berlin, DEU.
Raffaele HellwegBreast Unit, University Hospital Heidelberg, Heidelberg, DEU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Little is known about the opinion of professional academic immunologists regarding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Methodology In this study, we designed an online survey to determine the opinion of immunologically competent academics on SARS-CoV-2 compared with seasonal flu (the infection fatality rate, infectivity, the challenge to the health system, the importance of vaccine development, and the importance of the virulence of the virus and host factors), in addition to collecting demographic status variables and information sources used. Links to the survey were sent to all German-speaking immunologists, bacteriologists, virologists, and infectiologists in Germany, Austria, and Switzerland. Results A total of 91 full datasets were returned after three waves of requests. Approximately half of the respondents were male and half were more junior. Slightly more than half of the respondents said that the infection fatality rate and the infectivity were higher compared to flu, and 82% said that the challenge to the health system is higher. Overall, 52% found that the immune system is more important than the virus, and a majority (59%) supported the current practice of vaccination development by telescoping. A majority were of the view that conspiracy theories and non-pharmacological interventions pose a greater danger than the virus. Respondents who were more junior but well-published and mostly informed by public channels were more likely to support a mainstream view. Conclusions German-speaking immunological professionals hold widely diverging opinions regarding SARS-CoV-2. Over half of the surveyed professionals considered SARS-CoV-2 to be more dangerous and infective than the seasonal flu. However, the majority considered the health system to be under higher strain. Interestingly, more than half of them found host factors more important.

Indexed as

covid-19 vaccinationhosthost factorsimmune systemimmunology covid-19innate immune systemprimary surveyscale validation

Identifiers

PMID34925995
PMCPMC8655867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.